Overview
Efficacy of Jessener Solution Versus Intralesional Steroid in Treatment of Alopecia Areata
Status:
Recruiting
Recruiting
Trial end date:
2021-11-20
2021-11-20
Target enrollment:
0
0
Participant gender:
All
All
Summary
Alopecia areata is believed to be an autoimmune disease. Treatment primarily relies on intralesional and topical corticosteroids. This study was conducted to evaluate Jessener Solutionas a potential therapeutic modality of Alopecia Areataversusintralesional steroid as regards the efficacy, safety, tolerability, and patients' satisfaction.Phase:
Early Phase 1Accepts Healthy Volunteers?
Accepts Healthy VolunteersDetails
Lead Sponsor:
Al-Azhar University
Criteria
Inclusion Criteria:- 1.Alopecia Areatamultilocuolaris.2.Age from18-50years old. 3.Wash out period is two
months. 4.Ophiasis pattern alopecia areata.
Exclusion Criteria:
- Age less than 12 yearsand more than 40years old. 2.Patient under treatment.3.Patients
having another dermatological condition affecting thescalpas eczema.4.Patients with
psychiatric disorders.5.Pregnant and lactating females.